Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
14
NSHS.CX Quote, Financials, Valuation and Earnings
Last price:
$0.0200
Seasonality move
:
-25.65%
Day range:
$0.0200 - $0.0250
52-week range:
$0.0200 - $0.1750
Dividend yield:
0%
P/E ratio:
0.52x
P/S ratio:
--
P/B ratio:
--
Volume:
270K
Avg. volume:
9.5K
1-year change:
-55.56%
Market cap:
$205.5K
Revenue:
--
EPS (TTM):
$0.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
|
AGN.CX
Algernon Health, Inc.
|
-- | -- | -- | -- | -- |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0200 | -- | $205.5K | 0.52x | $0.00 | 0% | -- |
|
AGN.CX
Algernon Health, Inc.
|
$0.08 | -- | $2.7M | -- | $0.00 | 0% | -- |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
$0.05 | -- | $9.7M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
|
AGN.CX
Algernon Health, Inc.
|
-- | 0.270 | -- | 0.03x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
40.99% | -3.518 | 19.05% | 2.85x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
|
AGN.CX
Algernon Health, Inc.
|
-$8.7K | -$583.2K | -96.85% | -96.85% | -- | -$174.5K |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -$1.1M | -1117.27% | -- | -- | -$408.2K |
NanoSphere Health Sciences, Inc. vs. Competitors
-
Which has Higher Returns NSHS.CX or AGN.CX?
Algernon Health, Inc. has a net margin of -- compared to NanoSphere Health Sciences, Inc.'s net margin of --. NanoSphere Health Sciences, Inc.'s return on equity of -- beat Algernon Health, Inc.'s return on equity of -96.85%.
Company Gross Margin Earnings Per Share Invested Capital NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M AGN.CXAlgernon Health, Inc.-- -$0.02 $1.7M -
What do Analysts Say About NSHS.CX or AGN.CX?
NanoSphere Health Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Algernon Health, Inc. has an analysts' consensus of -- which suggests that it could grow by 3103.13%. Given that Algernon Health, Inc. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe Algernon Health, Inc. is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 AGN.CXAlgernon Health, Inc.0 0 0 -
Is NSHS.CX or AGN.CX More Risky?
NanoSphere Health Sciences, Inc. has a beta of 0.627, which suggesting that the stock is 37.292% less volatile than S&P 500. In comparison Algernon Health, Inc. has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.63%.
-
Which is a Better Dividend Stock NSHS.CX or AGN.CX?
NanoSphere Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Algernon Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NanoSphere Health Sciences, Inc. pays -- of its earnings as a dividend. Algernon Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NSHS.CX or AGN.CX?
NanoSphere Health Sciences, Inc. quarterly revenues are --, which are smaller than Algernon Health, Inc. quarterly revenues of --. NanoSphere Health Sciences, Inc.'s net income of -$13.1K is higher than Algernon Health, Inc.'s net income of -$583.2K. Notably, NanoSphere Health Sciences, Inc.'s price-to-earnings ratio is 0.52x while Algernon Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NanoSphere Health Sciences, Inc. is -- versus -- for Algernon Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K AGN.CXAlgernon Health, Inc.-- -- -- -$583.2K
-
Which has Higher Returns NSHS.CX or COOL.CX?
Core One Labs, Inc. has a net margin of -- compared to NanoSphere Health Sciences, Inc.'s net margin of --. NanoSphere Health Sciences, Inc.'s return on equity of -- beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About NSHS.CX or COOL.CX?
NanoSphere Health Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that NanoSphere Health Sciences, Inc. has higher upside potential than Core One Labs, Inc., analysts believe NanoSphere Health Sciences, Inc. is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is NSHS.CX or COOL.CX More Risky?
NanoSphere Health Sciences, Inc. has a beta of 0.627, which suggesting that the stock is 37.292% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock NSHS.CX or COOL.CX?
NanoSphere Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NanoSphere Health Sciences, Inc. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NSHS.CX or COOL.CX?
NanoSphere Health Sciences, Inc. quarterly revenues are --, which are larger than Core One Labs, Inc. quarterly revenues of --. NanoSphere Health Sciences, Inc.'s net income of -$13.1K is higher than Core One Labs, Inc.'s net income of --. Notably, NanoSphere Health Sciences, Inc.'s price-to-earnings ratio is 0.52x while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NanoSphere Health Sciences, Inc. is -- versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns NSHS.CX or CURE.X.CX?
Biocure Technology has a net margin of -- compared to NanoSphere Health Sciences, Inc.'s net margin of --. NanoSphere Health Sciences, Inc.'s return on equity of -- beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About NSHS.CX or CURE.X.CX?
NanoSphere Health Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that NanoSphere Health Sciences, Inc. has higher upside potential than Biocure Technology, analysts believe NanoSphere Health Sciences, Inc. is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is NSHS.CX or CURE.X.CX More Risky?
NanoSphere Health Sciences, Inc. has a beta of 0.627, which suggesting that the stock is 37.292% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NSHS.CX or CURE.X.CX?
NanoSphere Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NanoSphere Health Sciences, Inc. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NSHS.CX or CURE.X.CX?
NanoSphere Health Sciences, Inc. quarterly revenues are --, which are larger than Biocure Technology quarterly revenues of --. NanoSphere Health Sciences, Inc.'s net income of -$13.1K is higher than Biocure Technology's net income of --. Notably, NanoSphere Health Sciences, Inc.'s price-to-earnings ratio is 0.52x while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NanoSphere Health Sciences, Inc. is -- versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns NSHS.CX or HEAL.CX?
has a net margin of -- compared to NanoSphere Health Sciences, Inc.'s net margin of --. NanoSphere Health Sciences, Inc.'s return on equity of -- beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M HEAL.CX-- -- -- -
What do Analysts Say About NSHS.CX or HEAL.CX?
NanoSphere Health Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that NanoSphere Health Sciences, Inc. has higher upside potential than , analysts believe NanoSphere Health Sciences, Inc. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 HEAL.CX0 0 0 -
Is NSHS.CX or HEAL.CX More Risky?
NanoSphere Health Sciences, Inc. has a beta of 0.627, which suggesting that the stock is 37.292% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NSHS.CX or HEAL.CX?
NanoSphere Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NanoSphere Health Sciences, Inc. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NSHS.CX or HEAL.CX?
NanoSphere Health Sciences, Inc. quarterly revenues are --, which are larger than quarterly revenues of --. NanoSphere Health Sciences, Inc.'s net income of -$13.1K is higher than 's net income of --. Notably, NanoSphere Health Sciences, Inc.'s price-to-earnings ratio is 0.52x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NanoSphere Health Sciences, Inc. is -- versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K HEAL.CX-- -- -- --
-
Which has Higher Returns NSHS.CX or LOBE.CX?
Lobe Sciences Ltd. has a net margin of -- compared to NanoSphere Health Sciences, Inc.'s net margin of --. NanoSphere Health Sciences, Inc.'s return on equity of -- beat Lobe Sciences Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M LOBE.CXLobe Sciences Ltd.-- -$0.01 $5.9M -
What do Analysts Say About NSHS.CX or LOBE.CX?
NanoSphere Health Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Lobe Sciences Ltd. has an analysts' consensus of -- which suggests that it could grow by 14192.33%. Given that Lobe Sciences Ltd. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe Lobe Sciences Ltd. is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 LOBE.CXLobe Sciences Ltd.0 0 0 -
Is NSHS.CX or LOBE.CX More Risky?
NanoSphere Health Sciences, Inc. has a beta of 0.627, which suggesting that the stock is 37.292% less volatile than S&P 500. In comparison Lobe Sciences Ltd. has a beta of 0.215, suggesting its less volatile than the S&P 500 by 78.507%.
-
Which is a Better Dividend Stock NSHS.CX or LOBE.CX?
NanoSphere Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lobe Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NanoSphere Health Sciences, Inc. pays -- of its earnings as a dividend. Lobe Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NSHS.CX or LOBE.CX?
NanoSphere Health Sciences, Inc. quarterly revenues are --, which are smaller than Lobe Sciences Ltd. quarterly revenues of --. NanoSphere Health Sciences, Inc.'s net income of -$13.1K is higher than Lobe Sciences Ltd.'s net income of -$1.1M. Notably, NanoSphere Health Sciences, Inc.'s price-to-earnings ratio is 0.52x while Lobe Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NanoSphere Health Sciences, Inc. is -- versus -- for Lobe Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K LOBE.CXLobe Sciences Ltd.-- -- -- -$1.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
